New pill approach for tough prostate cancer shows promise
NCT ID NCT05081193
Summary
This study tested a new treatment approach for men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. Fifteen participants took high-dose oral testosterone pills for one week, then took a week off, repeating this cycle. If their cancer progressed, they switched to a different drug called enzalutamide. The goal was to see if this cycling oral testosterone treatment could control cancer growth and improve quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny Health Network
Pittsburgh, Pennsylvania, 15212, United States
-
Johns Hopkins Hospital
Baltimore, Maryland, 21231, United States
Conditions
Explore the condition pages connected to this study.